Companies House true 2022-07-01 2023-06-30 false 10241229 uk-bus:Director1 2022-07-01 2023-06-30 10241229 uk-bus:Director2 2022-07-01 2023-06-30 10241229 2022-07-01 2023-06-30 10241229 2023-06-30 10241229 uk-bus:EntityHasNeverTraded 2022-07-01 2023-06-30 10241229 uk-bus:FRS102 2022-07-01 2023-06-30 10241229 uk-bus:FullAccounts 2022-07-01 2023-06-30 10241229 uk-bus:AuditExempt-NoAccountantsReport 2022-07-01 2023-06-30 10241229 2022-06-30 10241229 uk-bus:OrdinaryShareClass1 2022-07-01 2023-06-30 10241229 uk-bus:OrdinaryShareClass2 2022-07-01 2023-06-30 10241229 uk-bus:OrdinaryShareClass3 2022-07-01 2023-06-30 10241229 uk-bus:PreferenceShareClass1 2022-07-01 2023-06-30 10241229 uk-bus:PreferenceShareClass2 2022-07-01 2023-06-30 10241229 uk-bus:PreferenceShareClass3 2022-07-01 2023-06-30 10241229 uk-core:ShareCapitalPreferenceShares 2023-06-30 10241229 uk-core:ShareCapitalPreferenceShares 2022-06-30 iso4217:GBP iso4217:GBP xbrli:shares xbrli:shares

Registered Number 10241229

RAN BIOLINKS (UK) LTD

Dormant Accounts

30 June 2023

RAN BIOLINKS (UK) LTD Registered Number 10241229

Balance Sheet as at 30 June 2023

2023 2022
£ £
Current assets
Cash at bank and in hand
100000
100000
Net assets
100000
100000
Issued share capital
100000 Ordinary Shares of £ 1 each 100000 100000
Total Shareholder funds
100000
100000

STATEMENTS

  1. For the year ending 30 June 2023 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 7 March 2024

And signed on their behalf by:
Ahmed Chakroun, Director